APA

Folprecht G., Pericay C., Saunders M. P., Thomas A., Lopez Lopez R., Roh J. K., Chistyakov V., Höhler T., Kim J., Hofheinz R., Ackland S. P., Swinson D., Kopp M., Udovitsa D., Hall M., Iveson T., Vogel A. & Zalcberg J. R. (20171227). Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Folprecht G, Pericay C, Saunders M P, Thomas A, Lopez Lopez R, Roh J K, Chistyakov V, Höhler T, Kim J-S, Hofheinz R-D, Ackland S P, Swinson D, Kopp M, Udovitsa D, Hall M, Iveson T, Vogel A and Zalcberg J R. 20171227. Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Folprecht G., Pericay C., Saunders M. P., Thomas A., Lopez Lopez R., Roh J. K., Chistyakov V., Höhler T., Kim J., Hofheinz R., Ackland S. P., Swinson D., Kopp M., Udovitsa D., Hall M., Iveson T., Vogel A. and Zalcberg J. R. (20171227). Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Folprecht G, Pericay C, Saunders M P, Thomas A, Lopez Lopez R, Roh J K, Chistyakov V, Höhler T, Kim J-S, Hofheinz R-D, Ackland S P, Swinson D, Kopp M, Udovitsa D, Hall M, Iveson T, Vogel A and Zalcberg J R. Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20171227.